There is no “one size fits all” treatment for prostate cancer. You should learn as much as possible about the many treatment options available and, in conjunction with your physicians, make a decision about what’s best for you. Because men diagnosed with localized prostate cancer today may live for many years (or decades), it is important to discuss not only cure, but also quality of life.

Your decision-making process will likely include a combination of clinical and psychological factors, including:

  • The need for therapy
  • Your level of risk
  • Your personal circumstances
  • Your desire for a certain therapy based on risks, benefits, and your intuition

For most men with newly diagnosed prostate cancer they should always be seen in consultation with a radiation oncologist and a urologist. For men with more aggressive disease, or metastatic disease, patients should also have a consultation with a medical oncologist. Multi-disciplinary care will give you the most comprehensive assessment of the available treatments and expected outcomes. Each physician has expertise in different areas and are likely less familiar with what the other physicians do. Many hospitals and universities have multidisciplinary prostate cancer clinics that can provide this consultation service.

Prostate Cancer Treatment Options

Treating Localized or Locally Advanced Prostate Cancer

A man diagnosed with localized or locally advanced prostate cancer has four major treatment options: observation, active surveillance, surgery, and radiation.   There are other nonstandard treatment options that patients may consider, which include cryotherapy, high-intensity focused ultrasound, and primary hormone therapy.  Choosing the best treatment for localized or locally advanced prostate cancer is generally based on the man’s age, the stage and grade of the cancer, the man’s general health, and the man’s evaluation of the risks and benefits of each therapy option.

Physicians think about localized or locally advanced prostate cancer is in terms of “risk groups”. are 3 general risk groups, that can further be subdivided to better personalize treatment for each patient.

  1. Low risk: Tumor confined to the prostate, PSA is <10, and grade 1 (or Gleason score 6)
  2. Intermediate risk: Tumor is confined to the prostate, PSA is 10-20, or grade 2 or 3 (or Gleason score 7)
  3. High risk: Tumor extends outside the prostate, PSA >20, or grade 4 or 5 (or Gleason score 8-10)

The treatment options for each risk group are very different and you should ask your Doctor what risk group of prostate cancer you have so you can better understand the most appropriate treatment options.

In general, for most cases of newly diagnosed localized or locally advanced prostate cancers, the chance of “cure” is equal whether you have radiation therapy or surgery.

Data from ProtecT for low and intermediate risk prostate cancer patients showing risk of dying from prostate cancer is the same with either surgery or radiation therapy:

Data from ProtecT for high risk prostate cancer showing risk of dying from prostate cancer is the same with either surgery or radiation therapy:

Putting it simply, if there were a treatment with a better chance of cure, that would be what every national guideline would recommend and we would never recommend you meet the other specialty.  Some cancers are treated with radiation without surgery, some cancers are treated with surgery without radiation, some cancers are treated with both, and some cancers are treated with neither.

The main difference between surgery and radiation therapy relates to quality of life and side effects.  Every patient has different priorities in regards to what aspects of quality of life means most to them.  So before we discuss the various treatments in detail, let’s make sure your understand common treatment related changes that occur with surgery, radiation therapy, and hormone therapy.

Local Treatments for Recurrent Prostate Cancer

The goal after surgery is for the PSA to become undetectable and after radiation therapy for it to become very low (often less than 1 ng/mL; it doesn’t go to zero because the normal prostate still makes some PSA).  In this section, we’ll look at what happens when PSA first starts to rise after surgery or radiation therapy, and why a secondary local treatment might be right for you.

In general, the most common site of failure after surgery or radiation therapy is local, meaning in or nearby the prostate. For this reason, treating the prostate region may provide a second chance of cure. However, in some men the PSA in being produced from disease outside the pelvis, such as cancer in the lymph nodes or bone, so additional local therapy is not right for everyone. Furthermore, a second form of local therapy has some degree of additional side effects in addition to the first local therapy one chooses.

 

Treatment Options for Advanced Disease

We typically refer to Advanced Disease as the state of prostate cancer that has grown beyond the prostate and is unlikely to be cured with surgery or radiation alone. After a man experiences PSA Progression after surgery or radiation, hormonal therapy is often given at some point, and often for many years. Some men will not require any therapy, however, if their PSA doubling time is quite prolonged. However, many men will continue to progress at some point despite the above hormonal treatments and require more aggressive therapy. This comes in the form of additional second and third-line hormonal therapies, chemotherapy, immunotherapy, bone-targeted agents, and investigational agents (many are in trials right now from new hormonal therapies to prostate cancer vaccines to bone-targeting drugs).

Important to Note

There is still some uncertainty about the exact right therapies for many men, and whether some even need immediate therapy. Clinical trials are being conducted to address these questions for future generations.

FDA Approved Drugs

For a list of FDA drugs approved to treat prostate cancer, please see here.

Learn More